Lily Motabar

Lily Motabar is a fourth year Ph.D. candidate in the Department of Chemical & Biomolecular Engineering at the University of Delaware. She is also a guest researcher at the National Institute of Standards and Technology. Her thesis research focuses on investigating the stability of monoclonal antibody (mAb) and adeno-associated virus vector formulations via characterization of biophysical attributes, including protein self-interactions, higher order structure, and aggregation. Prior to her graduate research, she performed purification process development for mAbs, bispecific antibodies, and viral vectors at AstraZeneca.